Treating malaria: new drugs for a new era

Affiliations

¹ Australian Army Malaria Institute, Brisbane, QLD 4051, Australia. Electronic address: dennis.shanks@defence.gov.au.
² Medicines for Malaria Venture, Geneva, Switzerland.

Free article

Comment

G Dennis Shanks et al. Lancet Infect Dis. 2017 Dec.

Free article

. 2017 Dec;17(12):1223-1224.

doi: 10.1016/S1473-3099(17)30475-9. Epub 2017 Sep 12.

¹ Australian Army Malaria Institute, Brisbane, QLD 4051, Australia. Electronic address: dennis.shanks@defence.gov.au.
² Medicines for Malaria Venture, Geneva, Switzerland.

No abstract available

Comment on

AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.
Koita OA, Sangaré L, Miller HD, Sissako A, Coulibaly M, Thompson TA, Fongoro S, Diarra Y, Ba M, Maiga A, Diallo B, Mushatt DM, Mather FJ, Shaffer JG, Anwar AH, Krogstad DJ. Koita OA, et al. Lancet Infect Dis. 2017 Dec;17(12):1266-1275. doi: 10.1016/S1473-3099(17)30365-1. Epub 2017 Sep 12. Lancet Infect Dis. 2017. PMID: 28916443 Free PMC article. Clinical Trial.